Categories: News

Spheryx Introduces xSight, a Revolutionary Particle Characterization Instrument, with Live Demonstrations at the 10th Annual PEGS Boston, April 8-12, 2019.

NEW YORK, April 4, 2019 /PRNewswire/ — Spheryx, Inc. will demonstrate xSight, their particle characterization instrument at PEGS Boston, April 8-12, 2019, in the Exhibit Hall at Seaport World Trade Center, Booth 500. PEGS Boston is the largest biologics event, drawing over 2,600 international participants interested in collaborating and sharing best practices in biologic therapeutics. xSight, uses Spheryx’s proprietary technology, Total Holographic Characterization®, to detect, count and characterize sub-visible particles in complex heterogeneous mixtures, including protein aggregates, a known safety hazard in biologic pharmaceuticals.

Additionally, Spheryx was selected from 4,500 applicants to participate in the Hello Tomorrow Global Summit in Paris, an annual competition to showcase start-ups that solve an unmet industrial, environmental or societal need.

Spheryx announces the addition of Dr. Ross Boltyanskiy in the roll of Senior Scientist. Dr. Boltyanskiy received his PhD in physics from Yale University, and was a Postdoctoral Research Fellow at Memorial Sloan Kettering. Dr. Laura Phillips, President and CEO, stated, “We are delighted to have Dr. Boltyanskiy on board. With his expertise in microscopy, opto-mechanical technology and data visualization, he is a welcome addition to the Spheryx team.”

About Spheryx, Inc.
Spheryx, Inc. is a privately held analytical services and instruments company providing Total Holographic Characterization® of colloidal materials. Spheryx’s proprietary technology uses holographic video microscopy to characterize each particle in colloidal dispersions and multi-component colloidal mixtures, offering unprecedented insights into these materials’ characteristics. Applications include R&D, quality assurance and manufacturing process control across a broad spectrum of industries, where characterization of colloids can enhance innovation, improve safety and reduce costs. For more information: https://www.spheryx.solutions/

Note: This news release contains forward-looking statements regarding future events. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or result to differ materially.

Contact: Laura Philips, CEO
lphilips@spheryx.solutions  
607-738-0100

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/spheryx-introduces-xsight-a-revolutionary-particle-characterization-instrument-with-live-demonstrations-at-the-10th-annual-pegs-boston-april-8-12-2019-300824410.html

SOURCE Spheryx, Inc.

Staff

Recent Posts

Accuryn Medical Announces Maclean Health FSS Contract Award

Accuryn Monitor Now Included in Department of Veteran Affairs (VA) Federal Supply Schedule (FSS)HAYWARD, CA…

31 mins ago

Southern Illinois Associates Selects eClinicalWorks Cloud EHR for Comprehensive Behavioral Health Tools

The psychiatry and behavioral health group to utilize practice management and patient engagement solutions to…

3 hours ago

Nym Named Among Top 25 Companies in Healthcare Software for 2024 by The Healthcare Technology Report

NEW YORK--(BUSINESS WIRE)--Nym, the leader in autonomous medical coding, today announced that it has been…

4 hours ago

LivaNova to Announce First-Quarter 2024 Results

LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call…

6 hours ago

Viz.ai Names Michael Herring as Chief Financial Officer

Seasoned financial leader brings experience at leading companies in healthcare and software as a service…

6 hours ago